• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中的氨基酸代谢:致病驱动因素与治疗机遇

Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities.

作者信息

Liu Yawen, Zong Xiangyun, Altea-Manzano Patricia, Fu Jie

机构信息

Department of Radiation Oncology, Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.

Department of Breast Surgery, Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.

出版信息

Protein Cell. 2025 Jul 19;16(7):506-531. doi: 10.1093/procel/pwaf011.

DOI:10.1093/procel/pwaf011
PMID:39973065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12275100/
Abstract

Amino acid metabolism plays a critical role in the progression and development of breast cancer. Cancer cells, including those in breast cancer, reprogram amino acid metabolism to meet the demands of rapid proliferation, survival, and immune evasion. This includes alterations in the uptake and utilization of amino acids, such as glutamine, serine, glycine, and arginine, which provide essential building blocks for biosynthesis, energy production, and redox homeostasis. Notably, the metabolic phenotypes of breast cancer cells vary across molecular subtypes and disease stages, emphasizing the need for patient stratification and personalized therapeutic strategies. Advances in multi-level diagnostics, including phenotyping and predictive tools, such as AI-based analysis and body fluid profiling, have highlighted the potential for tailoring treatments to individual metabolic profiles. Enzymes, such as glutaminase and serine hydroxymethyltransferase, often upregulated in breast cancer, represent promising therapeutic targets. Understanding the interplay between amino acid metabolism and breast cancer biology, alongside the integration of personalized medicine approaches, can uncover novel insights into tumor progression and guide the development of precision therapies. This review explores the metabolic pathways of amino acids in breast cancer, with a focus on their implications for personalized treatment strategies.

摘要

氨基酸代谢在乳腺癌的进展和发展中起着关键作用。癌细胞,包括乳腺癌细胞,会重新编程氨基酸代谢以满足快速增殖、存活和免疫逃逸的需求。这包括氨基酸摄取和利用的改变,如谷氨酰胺、丝氨酸、甘氨酸和精氨酸,它们为生物合成、能量产生和氧化还原稳态提供必需的构建块。值得注意的是,乳腺癌细胞的代谢表型在分子亚型和疾病阶段有所不同,这强调了患者分层和个性化治疗策略的必要性。多层次诊断的进展,包括表型分析和预测工具,如基于人工智能的分析和体液分析,突出了根据个体代谢谱定制治疗的潜力。在乳腺癌中经常上调的酶,如谷氨酰胺酶和丝氨酸羟甲基转移酶,是很有前景的治疗靶点。了解氨基酸代谢与乳腺癌生物学之间的相互作用,以及个性化医学方法的整合,可以揭示肿瘤进展的新见解,并指导精准治疗的发展。本综述探讨了乳腺癌中氨基酸的代谢途径,重点关注它们对个性化治疗策略的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9933/12275100/a602c9f022f4/pwaf011_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9933/12275100/5a503b61ce86/pwaf011_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9933/12275100/2fd508bd558b/pwaf011_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9933/12275100/7834b7b5948f/pwaf011_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9933/12275100/a602c9f022f4/pwaf011_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9933/12275100/5a503b61ce86/pwaf011_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9933/12275100/2fd508bd558b/pwaf011_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9933/12275100/7834b7b5948f/pwaf011_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9933/12275100/a602c9f022f4/pwaf011_fig4.jpg

相似文献

1
Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities.乳腺癌中的氨基酸代谢:致病驱动因素与治疗机遇
Protein Cell. 2025 Jul 19;16(7):506-531. doi: 10.1093/procel/pwaf011.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Systemic Inflammatory Response Syndrome全身炎症反应综合征
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Sexual Harassment and Prevention Training性骚扰与预防培训
7
Systematic screening of metabolic pathways to identify two breast cancer subtypes with divergent immune characteristics.对代谢途径进行系统筛查,以识别具有不同免疫特征的两种乳腺癌亚型。
Sci Rep. 2025 Jul 1;15(1):20996. doi: 10.1038/s41598-025-05179-7.
8
Citrullinemia Type II型瓜氨酸血症
9
Isolated Methylmalonic Acidemia孤立性甲基丙二酸血症
10
Advancements in Targeted Therapies and Pharmacogenomics for Personalized Breast Cancer Treatment: The Role of Gene SNPs in Treatment Resistance.靶向治疗与药物基因组学在个性化乳腺癌治疗中的进展:基因单核苷酸多态性在治疗耐药中的作用
Curr Gene Ther. 2025 Jun 27. doi: 10.2174/0115665232373621250618181424.

本文引用的文献

1
Aspartate signalling drives lung metastasis via alternative translation.天冬氨酸信号通过可变翻译驱动肺转移。
Nature. 2025 Feb;638(8049):244-250. doi: 10.1038/s41586-024-08335-7. Epub 2025 Jan 1.
2
A whole food, plant-based diet reduces amino acid levels in patients with metastatic breast cancer.全食物、植物性饮食可降低转移性乳腺癌患者的氨基酸水平。
Cancer Metab. 2024 Dec 19;12(1):38. doi: 10.1186/s40170-024-00368-w.
3
Mitochondria-based holistic 3PM approach as the 'game-changer' for individualised rehabilitation-the proof-of-principle model by treated breast cancer survivors.
基于线粒体的整体3PM方法作为个性化康复的“变革者”——乳腺癌幸存者治疗的原理验证模型
EPMA J. 2024 Nov 20;15(4):559-571. doi: 10.1007/s13167-024-00386-0. eCollection 2024 Dec.
4
Small-molecule targeting BCAT1-mediated BCAA metabolism inhibits the activation of SHOC2-RAS-ERK to induce apoptosis of Triple-negative breast cancer cells.靶向BCAT1介导的支链氨基酸代谢的小分子抑制SHOC2-RAS-ERK的激活以诱导三阴性乳腺癌细胞凋亡。
J Adv Res. 2024 Oct 28. doi: 10.1016/j.jare.2024.10.021.
5
Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancer.吲哚胺2,3-双加氧酶1在乳腺癌免疫抑制中的作用
Cancer Pathog Ther. 2023 Nov 7;2(4):246-255. doi: 10.1016/j.cpt.2023.11.001. eCollection 2024 Oct.
6
Tryptophan 2,3-dioxygenase-positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine-mediated ferroptosis resistance of metastatic cells and T cell dysfunction.色氨酸 2,3-双加氧酶阳性基质成纤维细胞通过犬尿氨酸介导的转移细胞铁死亡抵抗和 T 细胞功能障碍为乳腺癌肺转移提供燃料。
Cancer Commun (Lond). 2024 Nov;44(11):1261-1286. doi: 10.1002/cac2.12608. Epub 2024 Sep 2.
7
Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer.遗传风险、与健康相关的生活方式以及早发性总体癌症和乳腺癌的风险。
J Natl Cancer Inst. 2025 Jan 1;117(1):40-48. doi: 10.1093/jnci/djae208.
8
A comprehensive overview of liquid biopsy applications in pediatric solid tumors.液体活检在儿科实体瘤中的应用综述
NPJ Precis Oncol. 2024 Aug 3;8(1):172. doi: 10.1038/s41698-024-00657-z.
9
The significant role of amino acid metabolic reprogramming in cancer.氨基酸代谢重编程在癌症中的重要作用。
Cell Commun Signal. 2024 Jul 29;22(1):380. doi: 10.1186/s12964-024-01760-1.
10
Arginine Methylation of DDX3 by PRMT1 Mediates Mitochondrial Homeostasis to Promote Breast Cancer Metastasis.PRMT1 介导的 DDX3 精氨酸甲基化调控线粒体稳态促进乳腺癌转移。
Cancer Res. 2024 Sep 16;84(18):3023-3043. doi: 10.1158/0008-5472.CAN-23-3829.